<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous reports have shown that <z:chebi fb="0" ids="24402">glycosphingolipids</z:chebi> can modulate the activity of the insulin receptor, and studies in transgenic mice suggest a link between altered levels of various <z:chebi fb="0" ids="28892">gangliosides</z:chebi> and the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we show that an inhibitor of <z:chebi fb="0" ids="24402">glycosphingolipid</z:chebi> synthesis can improve <z:chebi fb="105" ids="17234">glucose</z:chebi> control and increase insulin sensitivity in two different diabetic animal models </plain></SENT>
<SENT sid="2" pm="."><plain>In the <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty rat, the <z:chebi fb="0" ids="50382">glucosylceramide synthase inhibitor</z:chebi> (1R,2R)-<z:chebi fb="0" ids="29019">nonanoic acid</z:chebi>[2-(2',3'-dihydro-benzo [1, 4] <z:chebi fb="44" ids="28119">dioxin</z:chebi>-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethyl-ethyl]- <z:chebi fb="0" ids="29337,32988">amide</z:chebi>-l-<z:chebi fb="4" ids="26849">tartaric acid</z:chebi> salt (Genz-123346) lowered <z:chebi fb="105" ids="17234">glucose</z:chebi> and A1C levels and <z:mp ids='MP_0005292'>improved glucose tolerance</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Drug treatment also prevented the loss of pancreatic beta-cell function normally observed in the <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty rat and preserved the ability of the animals to secrete insulin </plain></SENT>
<SENT sid="4" pm="."><plain>In the diet-induced <z:mp ids='MP_0001261'>obese</z:mp> mouse, treatment with Genz-123346 normalized A1C levels and <z:mp ids='MP_0005292'>improved glucose tolerance</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of the phosphorylation state of the insulin receptor and downstream effectors showed increased insulin signaling in the muscles of the treated <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty rats and diet-induced <z:mp ids='MP_0001261'>obese</z:mp> mice </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that inhibiting <z:chebi fb="0" ids="24402">glycosphingolipid</z:chebi> synthesis can significantly improve insulin sensitivity and <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis and may therefore represent a novel therapeutic approach for the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>